Business Description
Harrow Inc
NAICS : 325412
SIC : 2834
ISIN : US4158581094
Total Employee Number:
373Compare
Compare
Traded in other countries / regions
HROW.USA3IP.Germany Index Membership
Russell 2000Russell 3000 IPO Date
2007-04-30Description
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | 0.07 | |||||
Debt-to-Equity | 10.47 | |||||
Debt-to-EBITDA | 9.25 | |||||
Interest Coverage | 0.85 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.9 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31.9 | |||||
3-Year EPS without NRI Growth Rate | -18.6 | |||||
3-Year Book Growth Rate | 15.1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 38.45 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.84 | |||||
9-Day RSI | 48.33 | |||||
14-Day RSI | 53.43 | |||||
3-1 Month Momentum % | 1.46 | |||||
6-1 Month Momentum % | -20.24 | |||||
12-1 Month Momentum % | 7.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.48 | |||||
Quick Ratio | 2.3 | |||||
Cash Ratio | 1.04 | |||||
Days Inventory | 68.33 | |||||
Days Sales Outstanding | 121.08 | |||||
Days Payable | 147.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.6 | |||||
Shareholder Yield % | -3.02 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 74.11 | |||||
Operating Margin % | 7.32 | |||||
Net Margin % | -5.57 | |||||
EBITDA Margin % | 12.1 | |||||
FCF Margin % | -1.45 | |||||
OCF Margin % | 5.66 | |||||
ROE % | -31.93 | |||||
ROA % | -3.96 | |||||
ROIC % | 7.18 | |||||
3-Year ROIIC % | 14.9 | |||||
ROC (Joel Greenblatt) % | 24.76 | |||||
ROCE % | 4.98 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 166.81 | |||||
PS Ratio | 5.85 | |||||
PB Ratio | 53.73 | |||||
Price-to-Operating-Cash-Flow | 106.04 | |||||
EV-to-EBIT | 146.08 | |||||
EV-to-EBITDA | 53.76 | |||||
EV-to-Revenue | 6.51 | |||||
EV-to-Forward-Revenue | 5.04 | |||||
EV-to-FCF | -449.41 | |||||
Price-to-GF-Value | 0.96 | |||||
Price-to-Median-PS-Value | 1.74 | |||||
Earnings Yield (Greenblatt) % | 0.68 | |||||
FCF Yield % | -0.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HROW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Harrow Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 268.675 | ||
| EPS (TTM) ($) | -0.41 | ||
| Beta | 1.6463 | ||
| 3-Year Sharpe Ratio | 0.65 | ||
| 3-Year Sortino Ratio | 1.19 | ||
| Volatility % | 74.03 | ||
| 14-Day RSI | 53.43 | ||
| 14-Day ATR ($) | 2.103813 | ||
| 20-Day SMA ($) | 42.1975 | ||
| 12-1 Month Momentum % | 7.76 | ||
| 52-Week Range ($) | 28.5401 - 54.85 | ||
| Shares Outstanding (Mil) | 37.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Harrow Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Harrow Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-11 08:00 | In 121 days | ||
| Third quarter earnings results for 2026 | 2026-11-10 | In 119 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-12 08:00 | In 30 days | ||
| Second quarter earnings results for 2026 | 2026-08-11 | In 28 days | ||
| General meeting for 2026 | 2026-06-18 08:00 | 41.94 (+8.32%) | ||
| William Blair\'s 46(th) Annual Growth Stock Conference | 2026-06-03 08:40 | 32.86 (-3.24%) | ||
| First quarter earnings conference call for 2026 | 2026-05-12 08:00 | 38.04 (-2.01%) | ||
| First quarter earnings results for 2026 | 2026-05-11 | 38.23 (-2.10%) | ||
| Guidance call for 2026 | 2026-03-10 20:40 | 35.15 (-1.35%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-03 08:00 | 53.59 (+0.15%) |
Show
Entries
Harrow Inc Frequently Asked Questions
What is Harrow Inc(HROW)'s stock price today?
The current price of HROW is $41.37. The 52 week high of HROW is $54.85 and 52 week low is $28.54.
When is next earnings date of Harrow Inc(HROW)?
The next earnings date of Harrow Inc(HROW) is 2026-08-11 Est..
Does Harrow Inc(HROW) pay dividends? If so, how much?
Harrow Inc(HROW) does not pay dividend.
Guru Commentaries on NAS:HROW
Press Release
Articles on Harrow Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers